|
1
|
Fujii K, Miyata Y, Takahashi I, Koizumi H,
Saji H, Hoshikawa M, Takagi M, Nishimura T and Nakamura H:
Differential Proteomic Analysis between Small Cell Lung Carcinoma
(SCLC) and Pulmonary Carcinoid Tumors Reveals Molecular Signatures
for Malignancy in Lung Cancer. Proteomics Clin Appl.
12(e1800015)2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Bell SP and Dutta A: DNA replication in
eukaryotic cells. Annu Rev Biochem. 71:333–374. 2002.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Neves H and Kwok HF: In sickness and in
health: The many roles of the minichromosome maintenance proteins.
Biochim Biophys Acta Rev Cancer. 1868:295–308. 2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Liu YZ, Jiang YY, Hao JJ, Lu SS, Zhang TT,
Shang L, Cao J, Song X, Wang BS, Cai Y, et al: Prognostic
significance of MCM7 expression in the bronchial brushings of
patients with non-small cell lung cancer (NSCLC). Lung Cancer.
77:176–182. 2012.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Gonzalez MA, Pinder SE, Callagy G, Vowler
SL, Morris LS, Bird K, Bell JA, Laskey RA and Coleman N:
Minichromosome maintenance protein 2 is a strong independent
prognostic marker in breast cancer. J Clin Oncol. 21:4306–4313.
2003.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Kaur G, Balasubramaniam SD, Lee YJ,
Balakrishnan V and Oon CE: Minichromosome Maintenance Complex (MCM)
Genes Profiling and MCM2 Protein Expression in Cervical Cancer
Development. Asian Pac J Cancer Prev. 20:3043–3049. 2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Nasri Nasrabadi P, Nayeri Z, Gharib E,
Salmanipour R, Masoomi F, Mahjoubi F and Zomorodipour A:
Establishment of a CALU, AURKA, and MCM2 gene panel for
discrimination of metastasis from primary colon and lung cancers.
PLoS One. 15(e0233717)2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Goldstraw P and Groome P: Lung and pleural
tumours. In: TNM Classification of Malignant Tumours. 7th edition.
Sobin, LH, Gospodarowicz MK and Wittekind C (eds). Wiley-Blackwell,
Chichester, West Sussex, pp 136-150, 2009.
|
|
9
|
Travis W, Brambilla E and Müller-Hermelink
HK (eds): World Health Organization Classification of Tumours:
Pathology and Genetics of Tumors of the Lung, Pleura, Thymus and
Heart. IARC Press, Lyon, 2004.
|
|
10
|
Travis WD, Brambilla E, Noguchi M,
Nicholson AG, Geisinger KR, Yatabe Y, Beer DG, Powell CA, Riely GJ,
Van Schil PE, et al: International association for the study of
lung cancer/american thoracic society/european respiratory society
international multidisciplinary classification of lung
adenocarcinoma. J Thorac Oncol. 6:244–285. 2011.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Freeman A, Morris LS, Mills AD, Stoeber K,
Laskey RA, Williams GH and Coleman N: Minichromosome maintenance
proteins as biological markers of dysplasia and malignancy. Clin
Cancer Res. 5:2121–2132. 1999.PubMed/NCBI
|
|
12
|
Dudderidge TJ, Stoeber K, Loddo M,
Atkinson G, Fanshawe T, Griffiths DF and Williams GH: Mcm2,
Geminin, and KI67 define proliferative state and are prognostic
markers in renal cell carcinoma. Clin Cancer Res. 11:2510–2517.
2005.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Dudderidge TJ, McCracken SR, Loddo M,
Fanshawe TR, Kelly JD, Neal DE, Leung HY, Williams GH and Stoeber
K: Mitogenic growth signalling, DNA replication licensing, and
survival are linked in prostate cancer. Br J Cancer. 96:1384–1393.
2007.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Nishihara K, Shomori K, Fujioka S,
Tokuyasu N, Inaba A, Osaki M, Ogawa T and Ito H: Minichromosome
maintenance protein 7 in colorectal cancer: Implication of
prognostic significance. Int J Oncol. 33:245–251. 2008.PubMed/NCBI
|
|
15
|
Hua C, Zhao G, Li Y and Bie L:
Minichromosome Maintenance (MCM) Family as potential diagnostic and
prognostic tumor markers for human gliomas. BMC Cancer.
14(526)2014.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Veena VS, George PS, Rajan K, Chandramohan
K, Jayasree K and Sujathan K: Immunocytochemistry on Sputum Samples
Predicts Prognosis of Lung Cancer. J Cytol. 36:38–43.
2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Liu YZ, Wang BS, Jiang YY, Cao J, Hao JJ,
Zhang Y, Xu X, Cai Y and Wang MR: MCMs expression in lung cancer:
Implication of prognostic significance. J Cancer. 8:3641–3647.
2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Ramnath N, Hernandez FJ, Tan DF, Huberman
JA, Natarajan N, Beck AF, Hyland A, Todorov IT, Brooks JS and
Bepler G: MCM2 is an independent predictor of survival in patients
with non-small-cell lung cancer. J Clin Oncol. 19:4259–4266.
2001.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Bryant VL, Elias RM, McCarthy SM, Yeatman
TJ and Alexandrow MG: Suppression of Reserve MCM Complexes
Chemosensitizes to Gemcitabine and 5-Fluorouracil. Mol Cancer Res.
13:1296–1305. 2015.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Jia M, Zheng D, Wang X, Zhang Y, Chen S,
Cai X, Mo L, Hu Z, Li H, Zhou Z, et al: Cancer Cell enters
reversible quiescence through Intracellular Acidification to resist
Paclitaxel Cytotoxicity. Int J Med Sci. 17:1652–1664.
2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Jin Y, Xiong A, Zhang Z, Li S, Huang H, Yu
TT, Cao X and Cheng SY: MicroRNA-31 suppresses medulloblastoma cell
growth by inhibiting DNA replication through minichromosome
maintenance 2. Oncotarget. 5:4821–4833. 2014.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Liu F, Yuan JH, Huang JF, Yang F, Wang TT,
Ma JZ, Zhang L, Zhou CC, Wang F, Yu J, et al: Long noncoding RNA
FTX inhibits hepatocellular carcinoma proliferation and metastasis
by binding MCM2 and miR-374a. Oncogene. 35:5422–5434.
2016.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Zhang X, Teng Y, Yang F, Wang M, Hong X,
Ye LG, Gao YN and Chen GY: MCM2 is a therapeutic target of
lovastatin in human non-small cell lung carcinomas. Oncol Rep.
33:2599–2605. 2015.PubMed/NCBI View Article : Google Scholar
|
